Merck has been one of the stronger performers in big pharma over the past few years, and with the stock recently around ...

Merck (MRK) stock returned 69.6% over the year to October 8, 2026, against 16.3% for the S&P 500. The gain built up over a ...

Merck & Co., Inc. is currently listed on NYSE under MRK. One share of MRK stock can currently be purchased for approximately $145.60. Is Merck & Co., Inc. listed on the NASDAQ or NYSE? Merck & Co., ...

Moderna (MRNA) shares are paring back some of their recent gains on Thursday morning – but a Morgan Stanley analyst believes Merck (MRK) stock remains a buy following blockbuster cancer drug trial ...

Merck & Co. stock (ISIN US58933Y1055) was trading at EUR 130.41 at Lang & Schwarz on October 9, 2026 at 8:10 p.m. CEST, up ...

The differences in the dividends these three companies paid on the same day tell three very different income stories.

The medicines Merck sells today grew at their usual pace. What investors spent the year repricing was everything that comes next.

Merck & Co. stock is supported by DBS’s Buy rating with a USD 180.00 price target as of September 12, 2026. The company ...

After strong gains recorded in the previous session following a late-stage trial success for a cancer vaccine developed with Moderna (MRNA), Merck (MRK) slipped on Thursday as RBC Capital Markets ...

Pfizer plans to close the penicillin department at its Catania facility in Italy, putting about 330 jobs at risk out of a workforce of 550, according to major Italian trade unions, Filctem CGIL, Femca ...